Author name: andrewshd

Mindera Health is disrupting the world of medicine. Ashley takes you inside their Carlsbad headquarters to see how this new psoriasis predictive test is changing lives for the better. Mindera Health founder Toby Dickerson explains it all.   See More: Precision Medicine disrupts the medical world | FOX 5 San Diego & KUSI News The […]

Koya Medical, today announces topline results from its TEAYS trial. TEAYS (NCT05507346) is a prospective multi-center, randomized cross-over study comparing lower extremity lymphedema treatment effectiveness of Dayspring?, Koya’s non-pneumatic compression device (NPCD) with a traditional advanced pneumatic compression device (APCD).   The study met its primary endpoints, achieving statistically significant differences in limb volume reduction,

Procyrion is proud to be recognized as a Fierce15 Medtech company this year! Check out the interview with our CEO Eric Fain to learn more about our innovative Aortix™ technology and the potential it has to change the way patients with acute decompensated heart failure and cardiorenal syndrome are treated. Read more…

Innovative collaboration will improve patient outcomes and cost savings through reduced trial-and-error management of biologic therapies Mindera Health, developer of Mind.Px™, the first realization of precision medicine in psoriasis, has formed a partnership with LivinitiTM, an innovative Pharmacy Benefit Manager, to improve the management of moderate-to-severe psoriasis patients. This pilot program will utilize Mind.Px to

Podimetrics – Revolutionize diabetic foot care for your patients Skip to main content Skip to footer Download our new eBook today! Breaking Barriers: Combatting Diabetic Amputations in Communities of ColorPeople of Color bear the heaviest

HOUSTON, TX – February 5, 2024 – Procyrion™, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today the completion of a $57.7 million Series E funding round, including the conversion of $10.0 million of interim financing. These funds will be used to support the ongoing DRAIN-HF

February 2, 2024 – Woburn, MA Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product offerings, today announced that the company will be participating in the 2024 International Master Course on Aging Science (IMCAS) World Congress, taking place February 1 – 3, 2024, in Paris. Chief Executive Officer and President, Jon

HOUSTON, TX – NOVEMBER 30, 2023 – Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced the enrollment of the first patients in the company’s IDE pivotal trial. The DRAIN-HF (Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure) study will evaluate the Aortix™ percutaneous

San Diego, CA – November 27th, 2023 – Mindera Health™, a leading provider of precision medicine solutions for psoriasis, today announced that it will be relocating its commercial activities to a new office building at 1221 Liberty Way, Vista, CA 92081 on December 1st, 2023. The new facility is over 19,000 square feet and features

Company secures funding to fuel expansion of its Thoraguard® System; adds veteran medtech leader Timothy Still to Board of Directors Centese, Inc., a leader in digital surgery technology, announces the successful closing of its $15M Series B funding round. The round, led by Medical Technology Venture Partners with participation from new and existing investors, will